retatrutide phase 3 results october 2025 New data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide Phase 3 Updates: Significant

Nature Medicine, 30(6), 1639-1647

Tirzepatide and semaglutide are both effective medications for weight loss, but they work in different ways

Risks include: Unknown ingredients Incorrect dosing Contamination (especially dangerous with injections) Beyond safety, weight loss with GLP-1s requires medical guidance

Semaglutide: The Single Agonist Think of GLP-1 as your bodys natural signal for Ive had enough to eat. After a meal, it helps communicate fullness to the brain, slows how quickly food leaves the stomach, and reduces the urge to keep eating

doi: 10.1152/physrev.00034.2015

Tirzepatide and retatrutide (single molecule): A single engineered molecule that hits multiple receptors simplifies the formulation to one compound with one pharmacokinetic profile, and allows the balance of receptor activation to be tuned at the molecular-design level